Clinical Trial Data Demands Spur Changes: Impact of Rising Complexity on Data Management

As clinical studies continue to collect an increasingly varied set of data elements – from biomarker and genetic data to real world evidence derived from social media or mobile applications – the pharma industry is challenged with incompatible data sources that cannot be easily integrated into traditional EDC systems.  This incompatibility contributes to longer database lock timelines and other data management challenges.

This article, featuring commentary from ERT’s Brion Regan, addresses the database lock challenges trial sponsors are wrestling with and explores some strategic – yet practical – changes that can address this issue.

Read the article here.